Valuation — not yet established
No valuation for Amylyx Pharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($135.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 7 rounds
- ·Watchlist + deal alerts for Amylyx Pharmaceuticals
Create free account
No card required
Funding history
7 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2021 | Later Stage VC (Series C) | $135.0M | ▮ | ▮ |
| Jun 2020 | Early Stage VC | $30.0M | ▮ | ▮ |
| Dec 2019 | Debt | $14.8M | ▮ | ▮ |
| Nov 2018 | Debt | $13.0M | ▮ | ▮ |
| Jul 2017 | Debt | $1.8M | ▮ | ▮ |
| Aug 2016 | Seed Round | $4.1M | ▮ | ▮ |
| + 1 earlier rounds · a free account shows the full history | ||||
How Amylyx Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Amylyx Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Amylyx Pharmaceuticals raised?
- Amylyx Pharmaceuticals has raised $135.0M in total funding across 7 recorded rounds.
- When did Amylyx Pharmaceuticals last raise?
- Amylyx Pharmaceuticals last raised in Jul 2021 (Later Stage VC (Series C)), raising $135.0M.